CN Patent
CN108473468B — Ret的抑制剂
Assigned to Cable Chart Pharmaceutical Co · Expires 2020-06-16 · 6y expired
What this patent protects
本文提供野生型RET及其抗性突变体的抑制剂、包含所述化合物的药物组合物、以及使用所述化合物和组合物的方法。
USPTO Abstract
本文提供野生型RET及其抗性突变体的抑制剂、包含所述化合物的药物组合物、以及使用所述化合物和组合物的方法。
Drugs covered by this patent
- Gavreto (PRALSETINIB) · Rigel Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.